DEFERASIROX USE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH β-THALASSEMIA MAJOR: Preliminary Results

By Unal Sule   Kuskonmaz Baris   Hazirolan Tuncay   Eldem Gonca   Aytac Selin   Cetin Mualla   Uckan Duygu   Gumruk Fatma  

Pediatric Hematology and Oncology, Vol. 27, Iss. 6, 2010-08 ,pp. : 482-489

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Deferasirox on Renal, Cardiac and Hepatic Iron Load in Patients with ββ-Thalassemia Major: Preliminary Results

By Unal Sule   Hazirolan Tuncay   Eldem Gonca   Gumruk Fatma  

Pediatric Hematology and Oncology, Vol. 28, Iss. 3, 2011-03 ,pp. : 217-221

Informa Healthcare

Access to resources Recommend Favorite

Comparative Assessment of Deferiprone and Deferasirox in Thalassemia Major Patients in the First Two Decades-Single Centre Experience

By Zachariah Mathew   Tony Surekha   Bashir Wafa   Al Rawas Abdulhakim   Wali Yasser   Pathare Anil  

Pediatric Hematology and Oncology, Vol. 30, Iss. 2, 2013-02 ,pp. : 104-112

Informa Healthcare

Access to resources Recommend Favorite

The Effect of HFE Polymorphisms on Cardiac Iron Overload in Patients with Beta-Thalassemia Major

By Turedi Aysen   Oymak Yesim   Meşe Timur   Yaman Yöntem   Bayraktaroglu Selen   Alpman Asude   Ozkinay Ferda   Aydınok Yeşim   Vergin Canan  

Pediatric Hematology and Oncology, Vol. 30, Iss. 8, 2013-11 ,pp. : 755-760

Informa Healthcare

Access to resources Recommend Favorite

Detection of Early Cardiac Dysfunction in Patients with β-Thalassemia Major and Thalassemia Trait by Tissue Doppler Echocardiography

By Balci Yasemin Isik   Gurses Dolunay  

Pediatric Hematology and Oncology, Vol. 28, Iss. 6, 2011-08 ,pp. : 486-496

Informa Healthcare

Access to resources Recommend Favorite